GKIM
GILD icon

GW&K Investment Management’s Gilead Sciences GILD Stock Holding History

GW&K Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Sell
924
-40
-4% -$5.27K ﹤0.01% 457
2026
Q1 		$134K Hold
964
– – ﹤0.01% 423
2025
Q4 		$118K Buy
964
+6
+0.6% +$729 ﹤0.01% 437
2025
Q3 		$106K Sell
958
-3
-0.3% -$341 ﹤0.01% 435
2025
Q2 		$107K Buy
961
+183
+24% +$19.5K ﹤0.01% 421
2025
Q1 		$87K Buy
778
+150
+24% +$15.5K ﹤0.01% 420
2024
Q4 		$58K Buy
628
+36
+6% +$3.24K ﹤0.01% 455
2024
Q3 		$50K Buy
592
+83
+16% +$6.33K ﹤0.01% 467
2024
Q2 		$35K Buy
509
+125
+33% +$8.34K ﹤0.01% 476
2024
Q1 		$28K Sell
384
-48
-11% -$3.69K ﹤0.01% 488
2023
Q4 		$35K Buy
432
+35
+9% +$2.72K ﹤0.01% 440
2023
Q3 		$30K Sell
397
-5
-1% -$385 ﹤0.01% 440
2023
Q2 		$31K Buy
+402
New +$32.1K ﹤0.01% 422
2022
Q3 		– Sell
-187
Closed -$12K – 572
2022
Q2 		$12K Buy
187
+45
+32% +$2.79K ﹤0.01% 459
2022
Q1 		$8K Buy
+142
New +$9.08K ﹤0.01% 452

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GW&K Investment Management's GILD Position: Q2 2026 in Review

GW&K Investment Management reduced its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, selling an estimated $5.27K and leaving 924 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

GW&K Investment Management first reported a position in GILD in Q1 2022 and has held it in 15 quarters since. The position peaked at $134K in Q1 2026. 2,290 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GW&K Investment Management held 924 shares of Gilead Sciences worth $117K as of Q2 2026.
  • GW&K Investment Management sold 40 Gilead Sciences shares in Q2 2026, an estimated $5.27K.
  • Gilead Sciences made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #457 holding.
  • GW&K Investment Management first reported a position in Gilead Sciences in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's Gilead Sciences position peaked at $134K in Q1 2026.
  • 2,290 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.